Literature DB >> 16323141

Group A streptococcus (GAS) carbohydrate as an immunogen for protection against GAS infection.

Hemant Sabharwal1, Francis Michon, Daniel Nelson, Wenling Dong, Kathleen Fuchs, Roberto Carreno Manjarrez, Arun Sarkar, Catherine Uitz, Ann Viteri-Jackson, Romeo S Rodriguez Suarez, Milan Blake, John B Zabriskie.   

Abstract

Previous studies have shown that human serum containing anti-group A streptococcus carbohydrate (GAS CHO) antibodies were opsonic for different M protein-carrying serotypes. To investigate the role that anti-GAS CHO antibodies play in passive and active protection, mice were immunized subcutaneously or intranasally with GAS CHO conjugated to tetanus toxoid, and mortality and oral colonization were monitored after challenge with live GAS. Compared with control mice, immunized mice were significantly protected against systemic or nasal challenge with GAS. Furthermore, studies of serum samples and throat cultures from Mexican children revealed an inverse relationship between high serum titers of anti-GAS CHO antibodies and the presence of GAS in the throat. Anti-GAS CHO antibodies were also tested for cross-reactivity with human tissues and cytoskeletal proteins. No cross-reactivity was observed in either assay. The present study demonstrates that GAS CHO is both immunogenic and protective against GAS infections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16323141     DOI: 10.1086/498618

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  42 in total

1.  The prospect of vaccination against group A beta-hemolytic streptococci.

Authors:  Karen L Kotloff
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

Review 2.  Prevention and treatment of rheumatic heart disease in the developing world.

Authors:  Andrew C Steer; Jonathan R Carapetis
Journal:  Nat Rev Cardiol       Date:  2009-09-15       Impact factor: 32.419

3.  emm and C-repeat region molecular typing of beta-hemolytic Streptococci in a tropical country: implications for vaccine development.

Authors:  Andrew C Steer; Graham Magor; Adam W J Jenney; Joseph Kado; Michael F Good; David McMillan; Michael Batzloff; Jonathan R Carapetis
Journal:  J Clin Microbiol       Date:  2009-06-10       Impact factor: 5.948

4.  The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design.

Authors:  Nina M van Sorge; Jason N Cole; Kirsten Kuipers; Anna Henningham; Ramy K Aziz; Ana Kasirer-Friede; Leo Lin; Evelien T M Berends; Mark R Davies; Gordon Dougan; Fan Zhang; Samira Dahesh; Laura Shaw; Jennifer Gin; Madeleine Cunningham; Joseph A Merriman; Julia Hütter; Bernd Lepenies; Suzan H M Rooijakkers; Richard Malley; Mark J Walker; Sanford J Shattil; Patrick M Schlievert; Biswa Choudhury; Victor Nizet
Journal:  Cell Host Microbe       Date:  2014-06-11       Impact factor: 21.023

Review 5.  Carbohydrate vaccines: developing sweet solutions to sticky situations?

Authors:  Rena D Astronomo; Dennis R Burton
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

Review 6.  Immunological Outcomes of Antibody Binding to Glycans Shared between Microorganisms and Mammals.

Authors:  Preeyam Patel; John F Kearney
Journal:  J Immunol       Date:  2016-12-01       Impact factor: 5.422

7.  Neonatal Exposure to Commensal-Bacteria-Derived Antigens Directs Polysaccharide-Specific B-1 B Cell Repertoire Development.

Authors:  J Stewart New; Brian L P Dizon; Christopher F Fucile; Alexander F Rosenberg; John F Kearney; R Glenn King
Journal:  Immunity       Date:  2020-06-30       Impact factor: 31.745

Review 8.  Cutting edge issues in rheumatic fever.

Authors:  Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

9.  Defense from the Group A Streptococcus by active and passive vaccination with the streptococcal hemoprotein receptor.

Authors:  Ya-Shu Huang; Morly Fisher; Ziyad Nasrawi; Zehava Eichenbaum
Journal:  J Infect Dis       Date:  2011-06-01       Impact factor: 5.226

Review 10.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.